General Atlantic Portfolio

Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.

SciNeuro ×

SciNeuro is a clinical-stage biotechnology company focused on developing innovative medicines for patients with central nervous system diseases.

  • Sector: Life Sciences
  • Headquarters: Shanghai
  • Date Invested: 02/6/2020
  • Visit Website